The Report Guru

According to research report the blood flow measurement devices market is projected to reach $533.0 Million by 2021 from $343.6 Million in 2016, growing at a CAGR of 9.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243081818 The growth of the overall market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, technological advancements, and the influx of VC funding. In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the growing focus of industry players in the region, increasing geriatric population, and growing prevalence of non-communicable diseases. On the basis of product, the market is segmented into ultrasound and laser Doppler. In 2016, the ultrasound segment accounted for the largest share of the global blood flow measurement device market. Further

Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market. According to research report the global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265815900 • By type, the chemically competent cells segment is expected to dominate the market in 2017 • By application, the cloning segment is expected to dominate the market in 2017 • By end user, the academic research institutes segment is expected to dominate the market in 2017 • North America to dominate the competent cells market in 2017 By region, the competent cells market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The market is dominated by North A

According to research report the medical wearables market size is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a CAGR of 21.4 % during the forecast period. The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population, and rising focus on cost containment in healthcare delivery are driving the greater uptake of mobile technologies. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876 The Patches product segment accounted for the largest share of the Clinical-Grade Wearable market in 2019 Based on product type, the patches segment accounted for the largest share of the Clinical Wearable Market in 2019. The large share of this segment can be there have been significant technological advancements in medical wearable devices, which have helped improve the treatment outcomes for patients. Growing use of high-tech devices that are compact, user-friendly, and come wit

OR Integration Market The growth in this market is driven by the increasing adoption of minimally invasive surgical procedures, redevelopment projects & funding for improving OR infrastructure, and rising need to curtail healthcare costs. Also, emerging economies (such as China, India, Brazil, and Mexico) are expected to offer lucrative growth opportunities for market players during the forecast period. According to a new market research report OR Integration Market is projected to grow at a CAGR of 12.4% during the forecast period, to reach USD 1.7 billion by 2024 from USD 1.0 billion in 2019. Stryker Corporation (US), STERIS (US), KARL STORZ (Germany), and Olympus (Japan) are the key players operating in this market. Other prominent players in the market include Getinge (Sweden), Alvo Medical (Poland), Skytron (US), Merivaara (Finland), Brainlab (Germany), TRILUX Medical (Germany), caresyntax (US), Sony (Japan), Barco (Belgium), Arthrex (US), and Richard Wol

According to the new market research report defibrillators market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%. North America dominated the global defibrillators market in 2017. The growth in this market is driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for players in the market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549 The study involved four major activities in estimating the current market size for the defibrillators market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry expe

According to research report the Cancer Immunotherapy Market is projected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0%. This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global cancer immunotherapy market along with the estimates and forecasts of the revenue and market share analysis. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894 This growth can be attributed to factors such as increasing adoption of target therapy over traditional therapy, emergence of biosimilars, increasing demand for mAbs, high prevalence of cancer. Cancer immunotherapy drugs are designed to alter or boost the body’s natural immune response to fight cancer this market is research-driven with a high degree of dependence on the discovery of molecules that can generate an immune response against various indication

According to research the research report Life Science Analytics Market is projected to reach USD 33.2 billion by 2024 from USD 19.3 billion in 2019, at a CAGR of 11.5% during the forecast period. Industry Growth Factors - Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales and marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653 Top Segments - Based on delivery model, the life science analytics market is segmented into the on-demand model and on premise model. The on-

wearable healthcare devices market According to research report wearable healthcare devices market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 This market is largely driven by the increasing awareness of fitness and healthy lifestyles, development of technologically advanced products, growing geriatric population and subsequent increase in the incidence of chronic diseases, cost-containment in healthcare delivery, robust penetration of 3G and 4G networks for uninterrupted healthcare services, increasing penetration of smartphones and the growing number of smart-phone based healthcare apps and growing preference for wireless connectivity among healthcare providers are driving the growth of the global wearable healthcare devices industry. Growing adoption of mobile platforms, increasing adoption of AI and 5G

According to research report the precision medicine software market is projected to reach $2.0 billion by 2024 from $1.2 billion in 2019, at a CAGR of 11.5%. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. Also, emerging markets, cloud-based solutions, and artificial intelligence in precision medicine may act as an important boosting factor for the exponential growth of the precision medicine software market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247980900 The major players in the precision medicine software market include Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), and SOPHiA GENETICS SA (Switzerland). Analysis of the market developments

Medical device contract manufacturing is the system by which a manufacturing company makes medical devices or components of medical devices that can be later sold by another company. Medical device contract manufacturers specialize in a certain process or task and offer expertise from the frequent practice of their manufacturing. Service or services for customers, clients, and inventors of medical devices include product concept and development, process validation and verification, production, or highly specialized manufacturing, and packaging. According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%. Newer and advanced technologies necessitate the incorporation of advanced manufacturing methods, which result in increased overall costs. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851 Opportunity: High gr

Cancer Biomarkers Market Market Growth - According to research report the global cancer biomarkers market was valued at USD 11.5 billion in 2017 and is estimated to grow at a CAGR of 12.2% during the forecast period, to reach USD 20.4 billion by 2022. The increasing prevalence of cancer, rising government support for research on cancer biomarkers, growing use of biomarkers in drug discovery and development, and increasing use of biomarker tests for diagnostic purposes are the major factors that are driving the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202 Top Segments - The breast cancer segment accounted for the largest share of the cancer biomarkers market in 2016 Based on cancer type, the cancer biomarkers market is segmented into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-Hodgkins lymphoma, kidney, and other cancers (such as cervical, multiple myeloma, CNS, gastric,

Market Growth - The global in-vitro toxicology testing market size is projected to reach USD 12.7 billion by 2024 from USD 8.1 billion in 2019, growing at a CAGR of 9.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth factors for this market. Also, the increasing focus of the pharmaceutical and cosmetics industries on using in-vitro methods for product testing along with the improvement in silico methods for predictive toxicology studies are expected to offer significant opportunities for market growth in the coming years. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 Top Players - Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US),

MIS Instruments Market Market Growth Factors - According to research report MIS Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5%. The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Top Segments - Handheld instruments accounted for the largest share of the global MIS instruments market in 2018. Based on product, the MIS instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments. Handheld instruments accounted for the largest share of the MIS instruments market in 2018, owing to factors such as the increasing number of surg

Microbiology Testing Market Market Growth Factors: Growth in the Microbiology Testing Market can be attributed to the technological advancements in the disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis. On the other hand, reimbursement concerns and unfavorable regulatory scenario are expected to limit market growth to a certain extent. Market Size: The global Microbiology Testing Market is projected to reach USD 4.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 6.4% from 2018 to 2023. Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367 Top Players: The major players operating in the Microbiology Testing Market include bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories Inc. (US), Bio-Rad Laboratories Inc. (US), F. Hoffmann La

Structural Heart Devices Market Market Growth Factors: Growth in the structural heart devices market is mainly driven by factors such as the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favourable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases. According to research report the global structural heart devices market is projected to reach $15.08 billion by 2023 from $9.28 billion in 2018, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161123753 Market Segments: The report describes and studies the global structural heart devices market, by product, procedure, and region. It provides detailed information regarding the major factors influencing the growth of this market and the regulatory analysis impacting market dynamics. On the basis of product, the global str

Liquid Biopsy Market Market Growth Factors: The key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for non-invasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D. Market Size: According to the new market research Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350 Market Segments: Based on product and service, the liquid biopsy market is segmented into assay kits, instruments, and services. Among these, the assay kits segment is expected to be the fastest-growing segment in the product and services market during the forecast period. Factors such as the increasi

Dental Equipment Market Market growth factor: The study involved four major activities to estimate the current market size for dental equipment. Exhaustive secondary research was done to collect information on market, peer market and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments. Market Size: According to research report the global dental equipment market is projected to reach USD 7.52 billion by 2021 from an estimated USD 5.93 billion in 2016, at a CAGR of 4.9% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784 Based on product, the dental equipment market is split into general dental equipment, dental diagnostic equipment, a

wearable medical devices market Market Growth Factors: The growth of the market is attributed to the technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, and increasing awareness about physical fitness. Market Size: According to research report the wearable medical devices market is expected to reach USD 32.71 billion by 2027 from USD 6.22 billion in 2017, at a CAGR of 18.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 Market Segments: Based on type, the wearable medical devices market is segmented into activity monitors, smartwatches, smart clothing, and patches. The activity monitors segment is expected register the highest CAGR during the forecast period. The high growth of this segment can be attributed to factors such as the rising adoption of sedentary and unhealthy lifestyles, rising prevalence

Breast Cancer Liquid Biopsy Market Growth Factor: The key features driving the growth of this market include increasing prevalence of breast cancer, increasing preference for non-invasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D. Market Size: According to the new market research report Breast Cancer Liquid Biopsy Market is expected to reach USD 411.1 million by 2022, at a CAGR of 23.1%. Top Segments: By circulating biomarkers, cell-free DNA (cfDNA) is expected to account for the largest market share in 2017 Based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vehicles (EVs), and other circulating biomarkers. In 2017, the cfDNA segment is expected to account for the largest share of the breast cance

Key Factors Driving Growth in Precision Medicine Software Market: Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market. Also, emerging markets, cloud-based solutions, and artificial intelligence in precision medicine may act as an important boosting factor for the exponential growth of the precision medicine software market. On the other hand, the high cost of deployment, issues related to the secure storage of large volumes of sequenced data, lack of reimbursement for precision medicine-based treatments, and lack of skilled IT professionals in healthcare are the key factors that are expected to challenge market growth to a certain extent during the forecast period. Market Growth: According to research report the precision medicine so

The growth of the market is attributed to the technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, and increasing awareness about physical fitness. According to research report the wearable medical devices market is expected to reach USD 32.71 billion by 2027 from USD 6.22 billion in 2017, at a CAGR of 18.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 Based on type, the wearable medical devices market is segmented into activity monitors, smartwatches, smart clothing, and patches. The activity monitors segment is expected register the highest CAGR during the forecast period. The high growth of this segment can be attributed to factors such as the rising adoption of sedentary and unhealthy lifestyles, rising prevalence of lifestyle diseases, and growing awareness of health and fitness. Based on application,